StockData
CervoMed Inc. logo

CervoMed Inc. (CRVO) stock

CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.50−0.17 (-10.18%)

Close on Nov 17, 2026Market cap $22.68MP/E –Yield –

CervoMed price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

CervoMed's price to sales ratio was 72.3× on Nov 11, 2026, against 14.9× a year earlier. Over the last 3 years it ranged from 1.9× to 121.3×, with a median of 10.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202672.3×+60.4
2025Dec 31, 202511.9×+9.9
2024Dec 31, 20241.9×−7.4
2023Dec 29, 20239.3×–

More CervoMed figures

See a number that looks wrong?